Stepan (NYSE:SCL – Get Free Report) is expected to be announcing its Q4 2025 results before the market opens on Monday, February 23rd. Analysts expect Stepan to post earnings of $0.35 per share and revenue of $570.60 million for the quarter. Interested persons can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Monday, February 23, 2026 at 9:00 AM ET.
Stepan Stock Performance
Shares of SCL stock opened at $67.30 on Friday. The firm has a market cap of $1.52 billion, a price-to-earnings ratio of 33.99 and a beta of 1.05. Stepan has a 52-week low of $41.82 and a 52-week high of $68.00. The company has a quick ratio of 0.84, a current ratio of 1.30 and a debt-to-equity ratio of 0.29. The company’s 50 day moving average is $54.71 and its 200 day moving average is $49.71.
Hedge Funds Weigh In On Stepan
Several large investors have recently bought and sold shares of SCL. EverSource Wealth Advisors LLC lifted its holdings in Stepan by 206.5% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 521 shares of the basic materials company’s stock worth $28,000 after buying an additional 351 shares during the last quarter. Parallel Advisors LLC lifted its stake in Stepan by 700.0% during the fourth quarter. Parallel Advisors LLC now owns 688 shares of the basic materials company’s stock worth $33,000 after purchasing an additional 602 shares during the last quarter. Quarry LP purchased a new stake in Stepan during the third quarter worth approximately $34,000. Danske Bank A S acquired a new position in Stepan in the third quarter valued at approximately $43,000. Finally, Raymond James Financial Inc. acquired a new stake in Stepan during the second quarter worth approximately $100,000. Hedge funds and other institutional investors own 82.70% of the company’s stock.
Analyst Ratings Changes
View Our Latest Research Report on SCL
Stepan Company Profile
Stepan Company is a global manufacturer of specialty and intermediate chemicals, primarily known for its development and production of surfactants and related specialty products. The company’s portfolio includes a wide range of ingredients used to enhance the performance of consumer and industrial formulations, such as emulsifiers, foam control agents, odor control agents, antimicrobial products and performance additives. These products are integral components in cleaning solutions, personal care items, agrochemical formulations, coatings, oilfield treatments and polymer systems.
Serving a diverse set of end-markets, Stepan’s offerings address both consumer-facing and industrial applications.
Featured Articles
- Five stocks we like better than Stepan
- Elon Musk already made me a “wealthy man”
- America’s 1776 happening again
- [How To] Invest Pre-IPO In SpaceX With $100!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Elon Musk: This Could Turn $100 into $100,000
Receive News & Ratings for Stepan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stepan and related companies with MarketBeat.com's FREE daily email newsletter.
